Abstract
Leptin, tumor necrosis factor-α (TNF-α), and soluble TNF receptors are involved in weight regulation. Antipsychotic agents, such as clozapine, induce weight gain and increase circulating levels of these cytokines. To assess whether obesity-inducing antidepressants have a similar effect, we measured plasma cytokine levels in depressive inpatients during the first six weeks of treatment with tricyclic agents (amitriptyline or nortriptyline, n = 12), with paroxetine (n = 10), or without medication (n = 14). There was an increase in the body mass index at week 6 of treatment with the tricyclics, which was preceded by a significant increase in soluble TNF receptor p75 plasma levels. Circulating levels of leptin were not affected. Paroxetine and drug-free treatment did not affect any of these parameters. We conclude that weight gain induced by psychotropic agents may occur without increased circulating levels of leptin. However, activation of the TNF-α system might be an early and sensitive marker of ensuing weight gain.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
American Psychiatric Association. (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Press
Argiles JM, Lopez-Soriano J, Busquets S, Lopez-Soriano FJ . (1997): Journey from cachexia to obesity by TNF. FASEB 11: 743–751
Auwerx J, Staels B . (1998): Leptin. Lancet 351: 737–742
Berken GH, Weinstein DO, Stern WC . (1984): Weight gain: A side-effect of tricyclic antidepressants. J Affect Disord 7: 133–138
Brömel T, Blum WF, Ziegler A, Schulz E, Bender M, Fleischhaker C, Remschmidt H, Krieg JC, Hebebrand . (1998): Serum leptin levels increase rapidly after initiation of clozapine treatment. Mol Psychiatry 3: 76–80
Bustillo JR, Buchanan RW, Breier ID . (1996): Differential effect of clozapine on weight: A controlled study. Am J Psychiatry 153: 817–819
Chou RC, Stinson MW, Noble BK, Spengler RN . (1996): Beta-adrenergic receptor regulation of macrophage-derived tumor necrosis factor-alpha production from rats with experimental arthritis. J Neuroimmunol 67: 7–16
Clement HW, Buschmann J, Rex S, Grote C, Opper C, Gemsa D, Wesemann W . (1997): Effects of interferon-gamma, interleukin-1 beta, and tumor necrosis factor-alpha on the serotonin metabolism in the nucleus raphe dorsalis of the rat. J Neural Transm 104: 981–991
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannessian JP, Marco CC, McKee LJ, Bauer TL, Caro JF . (1996): Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292–295
Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T . (1998): Tumor necrosis factor-α in sera of obese patients: Fall with weight loss. J Clin Endocrinol Metab 83: 2907–2910
Finck BN, Kelley KW, Dantzer R, Johnson RW . (1998): In vivo and in vitro evidence for the involvement of tumor necrosis factor-α in the induction of leptin by lipopolysaccharide. Endocrinology 139: 2278–2283
Gaughran F, O'Neill E, Cole M, Collins K, Daly RJ, Shanahan F . (1998): Increased soluble interleukin-2 receptor levels in schizophrenia. Schizophr Res 29: 263–267
Hauner H, Bender M, Haastert B, Hube F . (1998): Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes 22: 1239–1243
Kawakami M, Cerami A . (1981): Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med 154: 631–639
Kawashima S, Hayashi M, Takii T, Kimura H, Zhang HL, Nagatsu A, Sakakibara J, Murata K, Oomoto Y, Onozaki K . (1998): Serotonin derivative, N-(p-coumaroyl) serotonin, inhibits the production of TNF-alpha, IL-1alpha, IL-1beta, and IL-6 by endotoxin-stimulated human blood monocytes. J Interfer Cytok Res 18: 423–428
Kessel JB, Simpson GM . (1995): Biological therapies: Tricyclic and tetracyclic drugs. In Kaplan HI, Sadock BJ (eds), Comprehensive Textbook of Psychiatry. IV. 6th ed. Baltimore, MD, Williams & Wilkins, pp 2099
Kraus T, Haack M, Schuld A, Hinze-Selch D, Kühn M, Uhr M, Pollmächer T . (1999): Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 156: 312–314
Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM . (1996): Abnormal splicing of the leptin receptor in diabetic mice. Nature 279: 632–635
Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R . (1995a): Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affective Disord 34: 301–309
Maes M, Meltzer HY, Buckley P, Bosmans E . (1995b): Plasma soluble interleukin-2 and transferrin receptor in schizophrenia and depression. Eur Arch Psychiatry Clin Sci 244: 325–329
Müller N, Ackenheil M . (1998): Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 22: 1–33
Old LJ . (1985): Tumor necrosis factor (TNF). Science 230: 630–632
Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F . (1995): Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540–543
Pijl H, Meinders E . (1996): Bodyweight change as an adverse effect of drug treatment: Mechanisms and management. Drug Safety 14: 329–342
Pollmächer T, Hinze-Selch D . (1998): Factors confounding studies of circulating soluble interleukin-2 receptor levels in schizophrenia. Schizophr Res 33: 123–124
Pollmächer T, Hinze-Selch D, Fenzel T, Kraus T, Schuld A, Mullington J . (1997): Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. Am J Psychiatry 154: 1763–1765
Pollmächer T, Hinze-Selch D, Mullington J . (1996): Effects of clozapine on cytokines and soluble cytokine receptors. J Clin Psychopharmacol 16: 403–409
Pollmächer T, Hinze-Selch D, Mullington J, Holsboer F . (1995): Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors. Arch Gen Psychiatry 52: 877–878
van der Poll T, Lowry SF . (1995): Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 3: 1–12
Wetterling T, Mussigbrodt HE . (1999): Weight gain: Side effect of atypical neuroleptics? J Clin Psychopharmacol 19: 312–316
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hinze-Selch, D., Schuld, A., Kraus, T. et al. Effects of Antidepressants on Weight and on the Plasma Levels of Leptin, TNF-α and Soluble TNF Receptors: A Longitudinal Study in Patients Treated with Amitriptyline or Paroxetine. Neuropsychopharmacol 23, 13–19 (2000). https://doi.org/10.1016/S0893-133X(00)00089-0
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(00)00089-0
Keywords
This article is cited by
-
Effects of antidepressant drug therapy with or without physical exercise on inflammatory biomarkers in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials
European Journal of Clinical Pharmacology (2022)
-
Psychiatric aspects of toxoplasmosis: an Indian perspective
Journal of Parasitic Diseases (2016)
-
Impact of lithium alone and in combination with antidepressants on cytokine production in vitro
Journal of Neural Transmission (2015)
-
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Neuropsychopharmacology (2011)
-
Psychopharmaka und Diabetes
Wiener Medizinische Wochenschrift (2011)
